NO830385L - Fremgangsmaate for fremstilling av en insulinopploesning - Google Patents

Fremgangsmaate for fremstilling av en insulinopploesning

Info

Publication number
NO830385L
NO830385L NO830385A NO830385A NO830385L NO 830385 L NO830385 L NO 830385L NO 830385 A NO830385 A NO 830385A NO 830385 A NO830385 A NO 830385A NO 830385 L NO830385 L NO 830385L
Authority
NO
Norway
Prior art keywords
preparing
procedure
insulin solution
insulin
solution
Prior art date
Application number
NO830385A
Other languages
English (en)
Other versions
NO161204C (no
NO161204B (no
Inventor
Jens Joergen Vejlgaard Brange
Svend Havelund
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of NO830385L publication Critical patent/NO830385L/no
Publication of NO161204B publication Critical patent/NO161204B/no
Publication of NO161204C publication Critical patent/NO161204C/no

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K13/00—Apparatus or processes specially adapted for manufacturing or adjusting assemblages of electric components
    • H05K13/06—Wiring by machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO830385A 1982-02-05 1983-02-04 Fremgangsm te for fremstilling av en insulinopploesn NO161204C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK49182 1982-02-05

Publications (3)

Publication Number Publication Date
NO830385L true NO830385L (no) 1983-08-08
NO161204B NO161204B (no) 1989-04-10
NO161204C NO161204C (no) 1989-07-19

Family

ID=8094159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830385A NO161204C (no) 1982-02-05 1983-02-04 Fremgangsm te for fremstilling av en insulinopploesn

Country Status (22)

Country Link
US (1) US4476118A (no)
JP (1) JPS58192818A (no)
AT (1) AT382780B (no)
AU (1) AU549981B2 (no)
BE (1) BE895832A (no)
CA (1) CA1203476A (no)
CH (1) CH657530A5 (no)
DE (1) DE3303860A1 (no)
ES (1) ES8500060A1 (no)
FI (1) FI78616C (no)
FR (1) FR2521009B1 (no)
GB (1) GB2114573B (no)
GR (1) GR77388B (no)
IE (1) IE54548B1 (no)
IT (1) IT1178455B (no)
LU (1) LU84632A1 (no)
NL (1) NL187269C (no)
NO (1) NO161204C (no)
NZ (1) NZ203189A (no)
PT (1) PT76195B (no)
SE (1) SE460948B (no)
ZA (1) ZA83742B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166971B1 (de) * 1984-06-09 1990-02-28 Hoechst Aktiengesellschaft Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
DE69622421T2 (de) * 1995-11-13 2003-03-20 Medtronic Minimed, Inc. Verfahren und zusammensetzungen zur verabreichung monomerer proteine
JP2000507812A (ja) * 1996-03-12 2000-06-27 ライフ テクノロジーズ，インコーポレイテッド 造血細胞培養栄養補充成分
ES2218622T3 (es) * 1996-07-26 2004-11-16 Aventis Pharma Deutschland Gmbh Derivados de insulina con actividad de union al zinc incrementada.
ZA984697B (en) * 1997-06-13 1999-12-01 Lilly Co Eli Stable insulin formulations.
EP1283051B1 (en) * 1997-06-13 2006-06-14 Eli Lilly And Company Stable insulin formulations
EP1028706B1 (en) * 1997-11-12 2003-07-09 Alza Corporation Buffered drug formulations for transdermal electrotransport delivery
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
HUP0104111A3 (en) * 1998-10-16 2002-05-28 Novo Nordisk As Stable concentrated insulin preparations for pulmonary delivery
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
DK1265630T3 (da) * 2000-03-24 2006-10-09 Genentech Inc Anvendelse af insulin til behandling af brusksygdomme
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
ES2360182T3 (es) 2002-05-07 2011-06-01 Novo Nordisk A/S Formulaciones solubles que comprenden insulina monomérica e insulina acilada.
US20050065066A1 (en) * 2002-12-20 2005-03-24 Kaarsholm Niels Christian Stabilised insulin compositions
DE60317565T2 (de) * 2002-12-20 2008-09-11 Novo Nordisk A/S Pharmazeutische zusammensetzungen mit insulin und insulin-hexamer-liganden
WO2004096266A1 (en) * 2003-05-02 2004-11-11 Novo Nordisk A/S Improved physical stability of insulin formulations
JP4463814B2 (ja) * 2003-08-05 2010-05-19 ノボ ノルディスク アクティーゼルスカブ 新規のインスリン誘導体
EP1773878B1 (en) 2004-07-19 2015-03-04 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
ATE519780T1 (de) * 2005-12-28 2011-08-15 Novo Nordisk As Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen
US20090136538A1 (en) * 2006-05-22 2009-05-28 Jan Jezek Stable vaccine formulation
GB0700523D0 (en) * 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
EP2134351B1 (en) 2007-03-13 2016-04-27 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
ES2744384T3 (es) * 2007-06-13 2020-02-24 Novo Nordisk As Formulación farmacéutica que comprende un derivado de insulina
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
JP5241849B2 (ja) 2007-11-16 2013-07-17 ノボ・ノルデイスク・エー／エス インスリン及びインスリン分泌性ペプチドを含む薬学的組成物
EP2328607A1 (en) * 2008-07-16 2011-06-08 Arecor Limited Stable formulation of a therapeutic protein
EP2341940A1 (en) * 2008-07-16 2011-07-13 Arecor Limited The stabilisation of proteins
JP4959005B2 (ja) * 2008-10-30 2012-06-20 ノボ・ノルデイスク・エー／エス 毎日の注射頻度より少ないインスリン注射での真性糖尿病の治療
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
BR112013010345A2 (pt) 2010-10-27 2017-07-25 Novo Nordisk As tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
ES2927800T3 (es) 2011-03-01 2022-11-11 Nutrition 21 Llc Composición de insulina y cromo para el tratamiento y la prevención de diabetes, hipoglicemia y trastornos relacionados
KR102205512B1 (ko) 2012-11-13 2021-01-20 아도시아 치환된 음이온성 화합물을 포함하는 속효성 인슐린 제형
NZ707160A (en) 2012-12-19 2016-08-26 Wockhardt Ltd A stable aqueous composition comprising human insulin or an analogue or derivative thereof
WO2014102623A1 (en) 2012-12-26 2014-07-03 Wockhardt Limited Pharmaceutical composition
TWI641381B (zh) * 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
EP2991672A1 (en) 2013-04-30 2016-03-09 Novo Nordisk A/S Novel administration regime
WO2015084694A2 (en) * 2013-12-04 2015-06-11 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
TW201630622A (zh) 2014-12-16 2016-09-01 美國禮來大藥廠 速效胰島素組合物
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
US20190290737A1 (en) * 2016-09-29 2019-09-26 Arecor Limited Novel formulations
PE20200017A1 (es) 2017-06-01 2020-01-06 Lilly Co Eli Composiciones de insulina de rapida accion
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882202A (en) * 1950-04-05 1959-04-14 Novo Terapeutisk Labor As Insulin crystal preparations and methods of producing them
US2787575A (en) * 1950-11-22 1957-04-02 Organon Zinc-glycine-insulin composition and production thereof
US2882203A (en) * 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
DE1044360B (de) * 1953-08-19 1958-11-20 Roskilde Medical Company Ltd R Verfahren zur Herstellung von Zinkinsulin mit erhoehtem Zinkgehalt
DE956098C (de) * 1954-02-18 1957-01-10 Dr Dr Guenther Weitzel Verfahren zur Herstellung zinkreicher Insulin-Komplexverbindungen
US3058885A (en) * 1957-06-08 1962-10-16 Novo Terapeutisk Labor As Process for treatment of insulin crystals and for production of insulin preparationstherefrom
US3014842A (en) * 1957-08-10 1961-12-26 Novo Terapeutish Lab A S Injectable bovine insulin crystal suspensions and process of producing same
US3091573A (en) * 1958-05-12 1963-05-28 Novo Terapeutisk Labor As Quick acting insulin preparation
FR1263220A (fr) * 1958-08-01 1961-06-09 Novo Terapeutisk Labor As Procédé de production d'une préparation d'insuline à action rapide
DK116527B (da) * 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3657425A (en) * 1969-03-12 1972-04-18 Burroughs Wellcome Co Beef insulin preparations
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
DK80781A (da) * 1980-02-29 1981-08-30 Hospital For Sick Children Oploesninger af polypeptider
EP0102976A1 (en) * 1982-03-03 1984-03-21 Nordisk Insulinlaboratorium A process for producing an insulin preparation

Also Published As

Publication number Publication date
US4476118A (en) 1984-10-09
AU549981B2 (en) 1986-02-20
ZA83742B (en) 1983-11-30
DE3303860A1 (de) 1983-08-18
BE895832A (fr) 1983-08-04
FI78616B (fi) 1989-05-31
NL8300440A (nl) 1983-09-01
LU84632A1 (fr) 1983-09-08
DE3303860C2 (no) 1989-12-28
FI830375L (fi) 1983-08-06
FR2521009A1 (fr) 1983-08-12
IE830220L (en) 1983-08-05
PT76195A (en) 1983-03-01
ES519533A0 (es) 1984-10-16
SE8300598L (sv) 1983-08-06
IT8319420A0 (it) 1983-02-04
NO161204C (no) 1989-07-19
GB2114573A (en) 1983-08-24
ATA38983A (de) 1986-09-15
JPH0367056B2 (no) 1991-10-21
FI830375A0 (fi) 1983-02-03
CH657530A5 (de) 1986-09-15
AT382780B (de) 1987-04-10
NL187269C (nl) 1991-08-01
PT76195B (en) 1986-01-27
NO161204B (no) 1989-04-10
AU1113683A (en) 1983-08-11
SE8300598D0 (sv) 1983-02-04
NL187269B (nl) 1991-03-01
JPS58192818A (ja) 1983-11-10
NZ203189A (en) 1985-07-31
FI78616C (fi) 1989-09-11
GR77388B (no) 1984-09-11
IE54548B1 (en) 1989-11-08
GB2114573B (en) 1985-05-01
CA1203476A (en) 1986-04-22
SE460948B (sv) 1989-12-11
GB8303133D0 (en) 1983-03-09
IT1178455B (it) 1987-09-09
ES8500060A1 (es) 1984-10-16
FR2521009B1 (fr) 1987-07-17

Similar Documents

Publication Publication Date Title
NO830385L (no) Fremgangsmaate for fremstilling av en insulinopploesning
DK162057C (da) Fremgangsmaade til fremstilling af et immunogent kompleks
NO813726L (no) Fremgangsmaate for fremstilling av piperazinyl-benzo-heterocykliske forbindelser
DK470583A (da) Fremgangsmaade til fremstilling af 1-phenyl-2-piperidinopropanolderivater
KR840005446A (ko) N--4-피페리딘아민의 제조방법
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK164383D0 (da) Fremgangsmade til fremstilling af phospholipidderivater
ES520249A0 (es) Procedimiento de producir preparaciones de insulina.
ES523701A0 (es) Procedimiento de preparar derivados de penicilina.
NO862587L (no) Fremgangsmaate for fremstilling av en injiserbar opploesning inneholdende et antitumorantracyklinglykosid.
DK347383D0 (da) Fremgangsmade til fremstilling af phospholipidderivater
ES536780A0 (es) Procedimiento de preparar nuevas bencensulfonil-lactamas
IT1143925B (it) Procedimento per preparare d-alfaam minoacidi
DK299483A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK283083D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK136481A (da) Fremgangsmaade til fremstilling af et insulinforstadium
ES521941A0 (es) Procedimiento de preparar derivados de penicilina.
DK71783D0 (da) Fremgangsmade til fremstilling af pyrimidonderivater
NO833655L (no) Fremgangsmaate for fremstilling av antigen
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
NO833128L (no) Fremgangsmaate til fremstilling av substituerte 1-pyridyloxy-3-indolylalkylamino-2-propanoler
KR840004092A (ko) N-치환-테트라하이드로티아진의 제조방법
NO833669L (no) Fremgangsmaate for elektroplettering
NO832938L (no) Fremgangsmaate for fremstilling av en karsinostatisk substans
IT1165371B (it) Procedimento per preparare pirenzepina

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN FEBRUARY 2003